Brain cancer trial tests tailored drug cocktails for better survival
NCT ID NCT02977780
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 22 times
Summary
This study tests several new drugs, alone or with standard chemotherapy, for people with newly diagnosed glioblastoma, an aggressive brain cancer. About 460 participants will receive one of the experimental treatments or standard care. The goal is to see if these combinations help people live longer and are safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic
ACTIVE_NOT_RECRUITINGCleveland, Ohio, 44195, United States
-
Columbia University Medical Center
ACTIVE_NOT_RECRUITINGNew York, New York, 10032, United States
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Huntsman Cancer Institute
ACTIVE_NOT_RECRUITINGSalt Lake City, Utah, 84112, United States
-
Lifespan / Rhode Island Hospital
ACTIVE_NOT_RECRUITINGProvidence, Rhode Island, 02903, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mayo Clinic
ACTIVE_NOT_RECRUITINGRochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UT MD Anderson Cancer Center
COMPLETEDHouston, Texas, 77030, United States
-
University of Alabama at Birmingham
ACTIVE_NOT_RECRUITINGBirmingham, Alabama, 35294, United States
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Virginia Health System
COMPLETEDCharlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.